Sanbio Group, of Tokyo, appointed Bijan Nejadnik chief medical officer in charge of development and regulatory affairs. Nejadnik held key roles at Johnson & Johnson, as well as pioneering clinical programs at Jazz Pharmaceuticals plc, Galena Biopharma Inc. and Eureka Therapeutics Inc.